Skip to main content

Table 4 Information on diabetes medications for the 41 study patients in the 3 groups

From: Glycated hemoglobin and glycated albumin in patients with diabetes undergoing hemodiafiltration

 Group A
Non-protein-leaking OHDF
Group B
Protein-leaking OHDF
Group C
Highly efficient protein-leaking OHDF
Number of patients20147
Insulin users (number)352
 Dipeptidyl peptidase-4 inhibitor (number)132
 α-Glucosidase inhibitor (number)001
 Glucagon-like peptide-1 receptor agonist (number)110
 Glinide (number)012
 Sulfonylurea (number)000
Non-insulin users (number)1472
 Dipeptidyl peptidase-4 inhibitor (number)1362
 α-Glucosidase inhibitor (number)511
 Glucagon like peptide-1 receptor agonist (number)110
 Glinide (number)030
 Sulfonylurea (number)100
Unused diabetes medications (number)323
  1. Including multiple users of diabetes medications